文献
J-GLOBAL ID:201802211626440817
整理番号:18A0572253
C型肝炎:ヨーロッパにおけるC型肝炎ウイルス(HCV)を除去するための成功した欧州と国家戦略のための末端重要要素の始まり【Powered by NICT】
Hepatitis C: The beginning of the end-key elements for successful European and national strategies to eliminate HCV in Europe
著者 (29件):
Papatheodoridis G. V.
(Medical School of National, Kapodistrian University of Athens, Athens, Greece)
,
Hatzakis A.
(Medical School of National, Kapodistrian University of Athens, Athens, Greece)
,
Cholongitas E.
(Medical School of National, Kapodistrian University of Athens, Athens, Greece)
,
Baptista-Leite R.
(Institute of Health Sciences, Catolica University of Portugal, Lisbon, Portugal)
,
Baptista-Leite R.
(Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands)
,
Baskozos I.
(Ministry of Health, Athens, Greece)
,
Chhatwal J.
(Massachusetts General Hospital’ s, Institute for Technology Assessment and Harvard Medical School, Boston, MA, USA)
,
Colombo M.
(Clinical and Research Center Humanitas, Rozzano, Italy)
,
Cortez-Pinto H.
(European Association for the Study of the Liver, Geneva, Switzerland)
,
Cortez-Pinto H.
(Faculdade de Medicina, Universidade de Lisbon, Lisbon, Portugal)
,
Craxi A.
(University of Palermo, Palermo, Italy)
,
Goldberg D.
(School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, Scotland, UK)
,
Gore C.
(Hepatitis C Trust, World Hepatitis Alliance, London, UK)
,
Kautz A.
(Leberhilfe Projekt gUG, Cologne, Germany)
,
Lazarus J. V.
(Barcelonai Institute for Global Health (ISGlobal), Hospital Clinic, University of Barcelona, Barcelona, Spain)
,
Lazarus J. V.
(CHIP, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark)
,
Mendao L.
(Portuguese Activist Group for HIV/AIDS Treatment, Lisbon, Portugal)
,
Mendao L.
(European AIDS Treatment Group, Brussels, Belgium)
,
Peck-Radosavljevic M.
(Department of Internal Medicine and Gastroenterology, Klagenfurt, Austria)
,
Razavi H.
(Center for Disease Analysis, Lafayette, CO, USA)
,
Schatz E.
(Correlation Network, Amsterdam, The Netherlands)
,
Tozuen N.
(Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey)
,
van Damme P.
(Antwerp University, Antwerp, Belgium)
,
van Damme P.
(Viral Hepatitis Prevention Board, Antwerp, Belgium)
,
Wedemeyer H.
(Hannover Medical School, Hannover, Germany)
,
Yazdanpanah Y.
(INSERM, Universite Paris Diderot, Paris, France)
,
Zuure F.
(Department of Infectious Diseases Research and Prevention, Public Health Service of Amsterdam, Amsterdam, The Netherlands)
,
Zuure F.
(Department of Internal Medicine, Amsterdam Infection and Immunity Institute (AI&II), Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands)
,
Manns M. P.
(Hannover Medical School, Hannover, Germany)
資料名:
Journal of Viral Hepatitis
(Journal of Viral Hepatitis)
巻:
25 Suppl S1
ページ:
6-17
発行年:
2018年
JST資料番号:
W2670A
ISSN:
1352-0504
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)